Briefing
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
Recruiting phase 2 trial using ctDNA testing to decide when to start routine treatment in people with HPV-associated malignancies (planned n=30). Brief title verified via ClinicalTrials.gov API v2 on 13 Nov 2026.
- Design: Phase 2 · Recruiting